Vimarsana
Biggest News Aggregation in the World

Page 31 - Priority Review News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Priority Review. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Priority Review Today - Breaking & Trending Today

FDA Approves Iloprost Injection For the Treatment of Adults With Severe Frostbite - Vimarsana News

FDA Approves Iloprost Injection For the Treatment of Adults With Severe Frostbite

Iloprost had also received Priority Review and Orphan Drug Designations for this indication, and FDA approval in 2004 for the treatment of pulmonary arterial hypertension.

FDA Approves First Medication to Treat Severe Frostbite - Vimarsana News

FDA Approves First Medication to Treat Severe Frostbite

The FDA approved an injection to treat severe frostbite in adults to reduce the risk of finger or toe amputation.

Source: fda.gov
FDA to Review MDMA-Assisted Therapy for Post-Traumatic Stress Disorder - Vimarsana News

FDA to Review MDMA-Assisted Therapy for Post-Traumatic Stress Disorder

The investigational therapy combines MDMA, a psychoactive drug, with psychological interventions that include psychotherapy, talk therapy and other supportive services.

Source: empr.com
Seladelpar Gets Priority Review for Primary Biliary Cholangitis - Vimarsana News

Seladelpar Gets Priority Review for Primary Biliary Cholangitis

Seladelpar is an investigational, first-in-class oral, selective peroxisome proliferator-activated receptor delta agonist.

Source: empr.com
Rocket Pharmaceuticals Announces Update on FDA Review Timeline of KRESLADI™ (marnetegragene autotemcel) for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I) - Vimarsana News

Rocket Pharmaceuticals Announces Update on FDA Review Timeline of KRESLADI™ (marnetegragene autotemcel) for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)

New Prescription Drug User Fee Act date of June 30, 2024 ...